Amylin Pharma (AMLN) Reports Q3 Loss of $0.19, Beats by 10c

October 20, 2009 4:11 PM EDT Send to a Friend

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) reports Q3 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Amylin Pharma (AMLN) Reports Q3 Loss of $0.19, Beats by 10c

Member Login

Free News Feed